The Indian Competition Authority reviews 15 years of enforcement and merger scrutiny in the pharmaceutical and life sciences sector, targeting trade association cartels, hospital excessive pricing and patent-related dominance concerns
The life sciences and pharmaceutical industry in India is of great significance globally as well as domestically, being the third largest (by volume) in the world. In addition to supplying more than half of the global vaccine demand, Indian pharmaceutical companies also supply around 40 per cent of the US demand for generics and around 25 per cent of all med
